Hagiwara M, Ohuchi E, Hongo K, Oki M, Wada K, Morikawa T, Kobashi K
Fuji Chemical Industries, Ltd., Toyama, Japan.
Jpn J Pharmacol. 1990 Mar;52(3):493-5. doi: 10.1254/jjp.52.493.
An angiotensin-II analogue with a sulfated tyrosine residue was prepared by arylsulfotransferase treatment of synthetic human angiotensin-II. Its biological activities were studied in isolated smooth muscles, and its effect on blood pressure was determined. The sulfated angiotensin-II (AII-S) was about 15-30 fold less potent than angiotensin-II (AII) for ileum contraction and gallbladder contraction. The hypertensive potency of AII-S was about 30-fold less than that of AII.